BioSpace News Archive

Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.

Avance Clinical, the Australian and North American market-leading CRO for biotechs, was asked to present its GlobalReady drug development solution to more than 45 Korean biotechs

Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the third quarter of 2023 on Thursday, November 2, 2023, following the close of market.

VolitionRx Limited announces the publication of a clinical paper1 which shows that Volition’s Nu.Q® NETs test is a promising biomarker for the evaluation of disease severity in septic shock patients and could play an important role in sepsis prognosis.

RegCell announced the appointment of Michael V. McCullar, Ph.D., MBA as its new President, Chief Executive Officer, and Representative Director.

Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal.

GE HealthCare (Nasdaq: GEHC) today announced a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS).

CEL-SCI Corporation reported that its Multikine* cGMP state-of-the-art dedicated manufacturing facility commissioning is substantially complete, a significant milestone toward a planned Biologics License Application with several regulatory agencies for approval of Multikine in the treatment of head and neck cancer.

Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting.

Omeros Corporation (Nasdaq: OMER) today announced that Andreas Grauer, M.D., has been named Omeros’ chief medical officer.